| (210) | Number of the EPO application | 19751807 |
| (220) | Filing date of the EPO application | 2019.02.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 43/2022, 2022.10.26 |
| (110) | EPO patent number | 3678649 |
| (21) | Number of the application | e 2020 0736 |
| (71) | Name(s) of applicant(s), code of the country | Aegis Therapeutics, LLC, US;
ARS Pharmaceuticals Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LOWENTHAL Richard, US;
MAGGIO Edward T., US;
BELL Robert G., US;
SHAH Pratik, US; |
| (73) | Name(s) of owner(s), code of the country | Aegis Therapeutics, LLC, US;
ARS Pharmaceuticals Inc., US; |
| (54) | Title of the invention | INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/137 (2006.01.01); A61K 9/08 (2006.01.01); A61K 47/26 (2006.01.01); A61P 27/14 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.08.31 |
| (30) | Priority | 201815890131, 2018.02.06, US; 201862784057 P, 2018.12.21, US; 201862685049 P, 2018.06.14, US; 201862734550 P, 2018.09.21, US |
| (86) | International application | PCT/US2019/016918, 2019.02.06 |
| (87) | International publication | WO 2019/157099, 2019.08.15 |